Emerging oligonucleotide therapeutics for rare neuromuscular diseases
Research and drug development concerning rare diseases are at the cutting edge of scientific technology. To date, over 7,000 rare diseases have been identified. Despite their individual rarity, 1 in 10 individuals worldwide is affected by a rare condition. For the majority of these diseases, there i...
Үндсэн зохиолчид: | Aoki, Y, Wood, MJA |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
IOS Press
2021
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Oligonucleotide-based therapies for neuromuscular disease
-н: Douglas, A, зэрэг
Хэвлэсэн: (2015) -
Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases
-н: Tsoumpra, MK, зэрэг
Хэвлэсэн: (2019) -
Advances in oligonucleotide drug delivery
-н: Roberts, TC, зэрэг
Хэвлэсэн: (2020) -
Recent advances in antisense oligonucleotide therapy in genetic neuromuscular diseases
-н: Ashok Verma
Хэвлэсэн: (2018-01-01) -
Cell-penetrating peptide conjugates of steric blocking oligonucleotides as therapeutics for neuromuscular diseases from a historical perspective to current prospects of treatment
-н: Gait, M, зэрэг
Хэвлэсэн: (2018)